Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs VNET Group Inc (VNET) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs VNET Group Inc — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $69.47 (market cap $30.93B), while VNET Group Inc trades at $4.46 (market cap $1.27B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 24.4× VNET Group Inc's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while VNET Group Inc pays none. Which is the better fit depends on your goals.
| GEHC | VNET | |
|---|---|---|
Market Cap | $30.93B | $1.27B |
Volume | 5,033,451 | 8,996,162 |
Sector | Health | Technology |
52-Week High | $88.16 | $14.03 |
52-Week Low | $59.48 | $4.49 |
Enterprise Value | $39.39B | $4.85B |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 16 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
VNET trades at $5.26, down 1.13% with bearish technical signals. The stock faces fundamental challenges with negative net income margin (-22.18%) and ROE (-46.49%), though revenue grew to $9.95B in 2025. Recent strategic investments and AI infrastructure demand provide growth catalysts, but high leverage and negative cash flow remain concerns. Analyst consensus is moderately bullish with 62.5% buy ratings despite recent earnings misses.
The outlook balances growth potential from AI data center demand against significant financial risks. While strategic partnerships and wholesale IDC expansion offer upside, persistent losses, rising debt, and negative cash flow create substantial shareholder risk. Investors should weigh the company's positioning in China's tech infrastructure against its challenging balance sheet reality.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About VNET Group Inc
VNET Group, formerly 21Vianet, is a leading carrier-neutral data center services provider in China. It operates a dual-core strategy: a large-scale retail business serving over 7,000 enterprise customers and an aggressive wholesale segment (Hyperscale 2.0) designed to meet the high-density power and cooling demands of large-scale AI and cloud platforms.
Read more on VNET →
